Cargando…
Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722334/ https://www.ncbi.nlm.nih.gov/pubmed/31616760 http://dx.doi.org/10.14309/crj.0000000000000075 |